scispace - formally typeset
S

Stefania Bruno

Researcher at University of Turin

Publications -  128
Citations -  15592

Stefania Bruno is an academic researcher from University of Turin. The author has contributed to research in topics: Stem cell & Mesenchymal stem cell. The author has an hindex of 51, co-authored 116 publications receiving 13277 citations. Previous affiliations of Stefania Bruno include Health Science University & Fresenius Medical Care.

Papers
More filters
Journal ArticleDOI

Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury

TL;DR: It is found that microvesicles derived from human bone marrow MSCs stimulated proliferation in vitro and conferred resistance of tubular epithelial cells to apoptosis, suggesting RNA-dependent biologic effects.
Journal ArticleDOI

Exosomes/microvesicles as a mechanism of cell-to-cell communication

TL;DR: The transfer of gene products from injured cells may explain stem cell functional and phenotypic changes without the need of transdifferentiation into tissue cells, and the evidence supporting a bidirectional exchange of genetic information between stem and injured cells is discussed.
Journal ArticleDOI

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Aravinthan Varatharaj, +125 more
TL;DR: This is the first nationwide, cross-specialty surveillance study of acute neurological and psychiatric complications of COVID-19 and provides valuable and timely data that are urgently needed by clinicians, researchers, and funders.
Journal ArticleDOI

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.

TL;DR: Protein expression and functional studies showed that PI3K and eNOS play a critical role in the angiogenic effect of MVs, suggesting that EPCs may activate angiogenesis in endothelial cells by releasing MVs able to trigger an angiogens program.
Journal ArticleDOI

Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury

TL;DR: It is found that a single administration of MVs, immediately after IRI, protects rats from AKI by inhibiting apoptosis and stimulating tubular epithelial cell proliferation, and suggests that MVs could be exploited as a potential new therapeutic approach.